hGH fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-02-13. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
=== Antebellum Politics in Knoxville === Early-19th century Knoxville was often caught in the middle of the sectionalist fighting between East Tennessee and the state as a whole. Following the presidential election of 1836, in which Knoxvillian Hugh Lawson White (James White's son) ran against Andrew Jackson's hand-picked successor, Martin Van Buren, political divisions in the city manifested along Whig (anti-Jackson) and Democratic party lines. In 1839, W.B.A. Ramsey won the city's first popular mayoral election by a single vote, illustrating how strong these divisions had become. In 1849, William G. "Parson" Brownlow moved his radical Whig newspaper, the Whig, to Knoxville. Brownlow's editorial style, which often involved vicious personal attacks, intensified the already-sharp political divisions within the city. In 1857, he quarreled with the pro-Secession Southern Citizen and its publishers, Knoxville businessman William G. Swan and Irish Patriot John Mitchell (then in exile), to the point of threatening Swan with a pistol. Brownlow's attacks drove Whig-turned-Democrat John Hervey Crozier from public life, and forced two directors of the failed Bank of East Tennessee, A.R. Crozier and William Churchwell, to flee town. He brought charges of swindling against a third director, J.G.M. Ramsey, the former railroad promoter and a staunch Democrat.
Acne vulgaris is a common chronic inflammatory pilosebaceous skin disorder associated with papules, pustules, or nodules primarily on the face. The separate and combined therapeutic effects of red and blue lights LEDT proved to be effective for acne therapy. Skin sebum plugs is the most typical cause of Acne.
The country declined several international offers of COVID-19 vaccines, making it one of the few countries not to begin a vaccination programme. North Korea began administering its first vaccine doses in late May 2022 to select soldiers. In May 2022, the Korean Central News Agency reported that an unspecified number of people in the capital Pyongyang tested positive for the virus, and announced the country's first confirmed deaths. Authorities announced over 1 million North Koreans were suffering from "fever". Kim Jong Un declared a national emergency and a country-wide lockdown. While NK News asserted that "fever" was used as a substitute for COVID-19 cases, the South Korean National Intelligence Service stated that the total included cases of waterborne diseases, such as measles and typhoid. In a discreet interview with the BBC through Daily NK, some North Koreans reported an alarming rate of food scarcity, as the country had stopped importing food supplies due to the pandemic. One woman reported her neighbours had died of starvation, and others said they were living in constant fear of death. On 5 May 2023, the World Health Organization (WHO) announced an end to the COVID-19 global health emergency.
Sources: en.wikipedia.org
== Aftermath == In the aftermath of the incident, security protocols at the facility were strengthened, including tighter restrictions on tool access. The North Carolina prison system also improved safety by equipping guards with body armor and providing supervisors with tasers. On October 12, 2022—the fifth anniversary of the failed escape—staff at Pasquotank held a moment of silence and released balloons in remembrance.
Before a blood transfusion is given, there are many steps taken to ensure the quality of the blood products, compatibility, and safety to the recipient. In 2012, a national blood policy was in place in 70% of countries, and 69% of countries had specific legislation that covers the safety and quality of blood transfusion.
This part of the County of London was transferred to the new London Borough of Newham in Outer London and Newham Council was therefore an education authority. The ILEA had a somewhat anomalous legal status. Technically the GLC itself was the education authority for inner London, but it was both administratively difficult and politically questionable to allow outer London members of the GLC to have an input. Therefore, the GLC delegated responsibility to the ILEA as a 'special committee', consisting of the members of the GLC from the Inner London area, plus one member delegated from each of the inner London boroughs and the City of London. Those who were members of both the GLC and the ILEA tended to concentrate on one duty only, although they attended the meetings of both bodies.
== Sources == Alhakim, Youssef (1983). Syria and the French Mandate (in Arabic). Beirut: Dar Al-Nahar. Bishour, Wadi' (1994). Syria: The Making of a State and the Birth of a Nation (in Arabic) (1st ed.). Damascus, Syria: Dar Al-Yaziji. Haddad, Ghassan Mohammed Rashad (2007). Shami Papers: Contemporary Syrian History 1946-1966 (in Arabic). Madbouly Library. ISBN 9789772086276. Archived from the original on 10 August 2020. Retrieved 9 February 2025. Torrey, Gordon (1964). Syrian Politics and the Military, 1945-1958. Ohio State University Press. Archived from the original on 10 August 2020.
Sources: en.wikipedia.org
Data published by the Home Office shows a 25% rise in reported incidents of religious hate crime over the past 12 months, largely against Muslims and Jews as a result of the Gaza war. 11 October Office for National Statistics figures show the UK economy grew by 0.2% during August, following two months of stagnation. Virginia McCullough, who murdered her parents in 2019 then lived in the family home alongside their bodies for four years, is sentenced to life imprisonment with a minimum term of 36 years. 12 October Alex Salmond, former first minister of Scotland, dies aged 69 in North Macedonia. A woman in her 20s is reported to have died after going overboard from a cruise ship near the Channel Islands in the early hours. 15 October Five people, including two children, are killed in a crash on the M6 in Cumbria. Former Chelsea boss Thomas Tuchel agrees to become the next England manager. 16 October Office for National Statistics figures show that UK inflation decreased unexpectedly to 1.7% in the year to September, its lowest level in over three years. A suspected gas explosion destroys three houses in Benwell, Newcastle, killing a seven-year-old boy and a man in his thirties, and hospitalising six other people. The University of Oxford rejects former Prime Minister of Pakistan Imran Khan's application to become chancellor. 17 October The National Gallery has banned liquids, such as baby formula and milk, from its premises following a number of attacks on artworks.
A soft-tissue sarcoma (STS) is a malignant tumor, a type of cancer, that develops in soft tissue. A soft-tissue sarcoma is often a painless mass that grows slowly over months or years. They may be superficial or deep-seated. Any such unexplained mass must be diagnosed by biopsy. Treatment may include surgery, radiotherapy, chemotherapy, and targeted drug therapy. Bone sarcomas are the other class of sarcomas. There are many different types, many of which are rarely found. The World Health Organization lists more than fifty subtypes.
However, those whose symptoms had remitted were significantly more likely to have good relationships with a romantic partner and at least one parent, good performance at work and school, a sustained work and school history, and good psychosocial functioning overall. Estimates of the lifetime risk of death by suicide among individuals with BPD range between 3% and 10%, varying with the method of investigation. In a study examining completed suicides among individuals aged 18 to 35, 30% of the suicides were attributed to people with BPD, with a majority being men, and almost none receiving treatment. Similar findings were reported in another study. Among men diagnosed with BPD, there is also evidence of a higher suicide rate: "men are more than twice as likely as women—18 percent versus 8 percent"—to die by suicide. There is evidence that a significant proportion of males who die by suicide may have undiagnosed BPD. About half of all individuals who commit suicide are diagnosed with a personality disorder, with BPD being the most common association.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.